Opportunity Information: Apply for PAS 17 022
The NIH grant opportunity "Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44)" (Funding Opportunity Number PAS-17-022) is an SBIR-focused program designed to help small businesses create, adapt, repurpose, or rigorously validate technology that supports non-pharmacological mind and body interventions. The core aim is to push practical, technology-driven advances that either measure key biological or behavioral processes relevant to these interventions or actively help people practice them more effectively, consistently, and with better outcomes. In other words, the program is interested in tools that can capture meaningful signals of how these interventions work in the real world and tools that can improve how well the interventions are delivered or adhered to, with an emphasis on mechanistic processes and functional outcomes.
Projects supported under this FOA can take several forms. Applicants may propose entirely new technologies, modifications of already-innovative devices or electronic systems, or new uses for existing devices and platforms that were originally built for other purposes. The FOA also explicitly allows component-level testing, meaning a company does not necessarily need to deliver a fully finished consumer-ready product at the outset. Instead, a proposal can focus on testing individual modules (for example, a sensor, algorithm, feedback interface, or stimulation component) or combinations of modules that could later become part of an integrated system. A major theme is the development of long-term, automated, and potentially wearable solutions, including systems that monitor, stimulate, or provide feedback in ways that help quantify or enhance the processes underlying mind and body approaches.
The "mind and body interventions" covered here are defined broadly but specifically as non-drug approaches. The FOA highlights three main categories: mind or brain-focused interventions such as meditation and hypnosis; body-based approaches such as acupuncture, massage, and spinal manipulation or mobilization; and combined mind-body meditative movement practices such as yoga, tai chi, and qigong. That scope signals that the NIH is open to a wide range of technologies, as long as they connect clearly to measurable processes or outcomes tied to these interventions. Examples of relevant technology directions might include systems that track physiological markers (such as heart rate variability or respiration), behavioral markers (such as movement patterns or adherence), or platforms that guide users through optimized practice using personalized, data-driven feedback. The FOA also accommodates technologies aimed at improving efficacy, which could include adaptive coaching systems, biofeedback solutions, or devices that help standardize delivery and dosage of an intervention in research or real-world settings.
From an eligibility standpoint, this opportunity is intended for small business concerns applying through the SBIR mechanism, using the R43/R44 phased structure commonly associated with feasibility and development stages. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible to apply. However, the announcement notes that "foreign components" as defined by the NIH Grants Policy Statement may be allowed, which generally means limited, well-justified elements of the project may occur outside the U.S. under NIH rules, but the applicant organization itself must be a qualifying U.S. small business and the project must remain compliant with NIH policy.
Administratively, the sponsoring agency is the National Institutes of Health, the instrument type is a grant, and the activity category is health (CFDA 93.213). The FOA was created on 2016-10-19, and the original closing date listed is 2020-01-05. The posted summary does not specify an award ceiling or expected number of awards, so applicants would typically need to consult the full FOA text and NIH SBIR budget guidelines for the relevant year to understand budget caps, phase limits, and any institute-specific expectations. Overall, the opportunity is geared toward turning mind-body intervention technologies into measurable, testable, and scalable tools, especially those that can operate over the long term, in automated and wearable formats, and that can strengthen both scientific understanding (mechanisms and monitoring) and real-world impact (optimization and efficacy).Apply for PAS 17 022
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
- This funding opportunity was created on 2016-10-19.
- Applicants must submit their applications by 2020-01-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)
Previous opportunity: Health Promotion Among Racial and Ethnic Minority Males (R21)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAS 17 022
Applicants also applied for:
Applicants who have applied for this opportunity (PAS 17 022) also looked into and applied for these:
| Funding Opportunity |
|---|
| Revision Requests for Active Alzheimer's Disease Core Centers (P30) Apply for PAR 17 019 Funding Number: PAR 17 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 17 025 Funding Number: PAR 17 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Renewal of the Longevity Consortium (U19) Apply for PAR 17 024 Funding Number: PAR 17 024 Agency: National Institutes of Health Category: Health Funding Amount: $6,155,384 |
| Brain Lymphatic System in Aging and Alzheimer's Disease (R01) Apply for RFA AG 17 055 Funding Number: RFA AG 17 055 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Human Cell Biology of Genetic Variants in Alzheimer's Disease (R01) Apply for RFA AG 17 053 Funding Number: RFA AG 17 053 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems Biology Approaches to Alzheimers Disease Using Non-mammalian Laboratory Animals (R01) Apply for RFA AG 17 057 Funding Number: RFA AG 17 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01) Apply for PAR 17 029 Funding Number: PAR 17 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Common Mechanisms and Interactions Among Neurodegenerative Diseases (R01) Apply for PAS 17 028 Funding Number: PAS 17 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01) Apply for PAR 17 031 Funding Number: PAR 17 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01) Apply for RFA AG 17 051 Funding Number: RFA AG 17 051 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01) Apply for PAR 17 032 Funding Number: PAR 17 032 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01) Apply for PAR 17 033 Funding Number: PAR 17 033 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Apply for PAR 17 035 Funding Number: PAR 17 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R33) Apply for RFA AG 17 060 Funding Number: RFA AG 17 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01) Apply for PAR 17 038 Funding Number: PAR 17 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42) Apply for PAR 17 036 Funding Number: PAR 17 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R21/R33) Apply for RFA AG 17 059 Funding Number: RFA AG 17 059 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33) Apply for PAR 17 037 Funding Number: PAR 17 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25) Apply for PAR 17 040 Funding Number: PAR 17 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Focused Technology Research and Development (R01) Apply for PAR 17 045 Funding Number: PAR 17 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAS 17 022", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
